Home › Trial NCT02400437
Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia
- Trial IDNCT02400437
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorDana-Farber Cancer Institute
- Enrollment26
- Start date2015-04
- ConditionsWaldenstrom's Macroglobulinemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.